Paul Jansson
Impact in
-
- Schizophrenia research and treatment
Papers in
-
- Chronic Obstructive Pulmonary Disease (COPD) Research 3
- Respiratory Support and Mechanisms 1
- Inhalation and Respiratory Drug Delivery 1
-
- Asthma and respiratory diseases 2
- Co-authors
- Ralph Brattsand (1 shared paper)Anna Runström (1 shared paper)Anna Miller‐Larsson (1 shared paper)F.‐A. Wiesel (1 shared paper)Göran Sedvall (1 shared paper)Lars Farde (1 shared paper)A. Wahlén (1 shared paper)Naimish Patel (3 shared papers)
- Journals
- Journal of Medicinal Chemistry (2 papers)American Journal of Respiratory and Critical Care Medicine (2 papers)Journal of Pharmacology and Experimental Therapeutics (1 paper)Journal of Hypertension (1 paper)Psychopharmacology (1 paper)
- Partner nations
- SwedenUnited KingdomNetherlands
In The Last Decade
Paul Jansson
8 papers receiving 284 citations
Peers
Comparison fields: 5 of 61
- Biological Psychiatry 11
- Psychiatry and Mental health 49
- Physiology 86
- Pulmonary and Respiratory Medicine 103
- Cellular and Molecular Neuroscience 57
Countries citing papers authored by Paul Jansson
This map shows the geographic impact of Paul Jansson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Jansson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Jansson more than expected).
Fields of papers citing papers by Paul Jansson
This network shows the impact of papers produced by Paul Jansson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Jansson. The network helps show where Paul Jansson may publish in the future.
Co-authors
The 25 scholars most cited alongside Paul Jansson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1988 | 94 | |
| 2 | 2017 | 70 | |
| 3 | 2000 | 69 | |
| 4 | 2018 | 22 | |
| 5 | 2020 | 20 | |
| 6 | 2017 | 11 | |
| 7 | 2018 | 4 | |
| 8 | Pharmacokinetics of remoxipride controlled release and immediate release capsules in schizophrenic patients. | 1990 | 2 |
| 9 | 2015 | 1 | |
| 10 | 2025 | 0 |
About Paul Jansson
Paul Jansson is a scholar working on Pulmonary and Respiratory Medicine, Physiology, Endocrine and Autonomic Systems, Psychiatry and Mental health and Molecular Biology, having authored 10 papers that have together received 293 indexed citations. Recurring topics across this work include Chronic Obstructive Pulmonary Disease (COPD) Research (3 papers), Schizophrenia research and treatment (2 papers), Regulation of Appetite and Obesity (2 papers), Asthma and respiratory diseases (2 papers), Cardiovascular and exercise physiology (1 paper), Respiratory Support and Mechanisms (1 paper), S100 Proteins and Annexins (1 paper) and Inhalation and Respiratory Drug Delivery (1 paper). The work is most often cited by research in Biological Psychiatry (11 citations), Psychiatry and Mental health (49 citations), Physiology (86 citations), Pulmonary and Respiratory Medicine (103 citations) and Cellular and Molecular Neuroscience (57 citations). Paul Jansson has collaborated with scholars based in Sweden, United Kingdom and Netherlands. Frequent co-authors include Ralph Brattsand, Anna Runström, Anna Miller‐Larsson, F.‐A. Wiesel, Göran Sedvall, Lars Farde, A. Wahlén, Naimish Patel, Raolat M. Abdulai and Michael I. Polkey. Their work appears in journals such as Journal of Medicinal Chemistry, American Journal of Respiratory and Critical Care Medicine, Journal of Pharmacology and Experimental Therapeutics, Journal of Hypertension and Psychopharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.